<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Among people with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, there is a 20-fold higher risk of dying suddenly and unexpectedly compared with the general population </plain></SENT>
<SENT sid="1" pm="."><plain>This phenomenon is called sudden unexpected <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e>) and the term is used when <z:hpo ids='HP_0001699'>sudden death</z:hpo> occurs in an otherwise reasonably healthy person with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> and the autopsy is unrevealing </plain></SENT>
<SENT sid="2" pm="."><plain>In most cases, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> occurs during sleep and is unwitnessed </plain></SENT>
<SENT sid="3" pm="."><plain>Risk factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> include the presence or number of <z:hpo ids='HP_0002069'>generalized tonic-clonic seizures</z:hpo> (GTCS), nocturnal <z:hpo ids='HP_0001250'>seizures</z:hpo>, young age at <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>, longer duration of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, <z:hpo ids='HP_0000726'>dementia</z:hpo>, absence of cerebrovascular disease, <z:hpo ids='HP_0002099'>asthma</z:hpo>, male gender, symptomatic aetiology of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> and <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Suggested factors predisposing to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> have included long-QT-related mutations, impaired serotonergic brain stem control of respiration, altered autonomic control and <z:hpo ids='HP_0001250'>seizures</z:hpo> with a pronounced postictal suppression and respiratory compromise </plain></SENT>
<SENT sid="5" pm="."><plain>Final events that may lead up to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> are a postictal <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> shutdown with pronounced EEG suppression, ictal or postictal <z:hpo ids='HP_0002104'>apnoea</z:hpo>, and ictal <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>It is unknown whether <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs (AEDs) modify the risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Studies have consistently found that the presence or number of GTCS is associated with an increased risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Since continued presence of GTCS clearly necessitates the use of AEDs, both factors must be taken into account to determine whether one or both increases the risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Some studies suggest that AEDs, such as lamotrigine and carbamazepine, may increase the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e>, but rarely adjust for GTCS </plain></SENT>
<SENT sid="10" pm="."><plain>Other studies, which have found that AEDs are associated with a decreased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> risk, either adjust for the number of GTCS or are meta-analyses of randomized clinical trials </plain></SENT>
<SENT sid="11" pm="."><plain>Studies assessing the impact of AEDs on the risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> are limited because <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> is a rare event, making randomized clinical trials impossible to conduct </plain></SENT>
<SENT sid="12" pm="."><plain>Observational studies focus on whether or not an AED was prescribed </plain></SENT>
<SENT sid="13" pm="."><plain>When postmortem AED concentrations are assessed they are usually low or absent, perhaps due to sampling in deceased individuals, making it difficult to fully resolve whether AEDs increase or decrease <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> risk </plain></SENT>
<SENT sid="14" pm="."><plain>Despite these caveats, the evidence suggests that AEDs are not associated with an increased risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> on a population level, although some individuals may be susceptible to effects of AEDs </plain></SENT>
<SENT sid="15" pm="."><plain>Recent evidence from a meta-analysis of randomized clinical trials of adjunctive AEDs at efficacious doses provides strong support for AED treatment as mono- or polytherapy to increase <z:hpo ids='HP_0001250'>seizure</z:hpo> control and protect against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> in patients with refractory <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>For patients for whom <z:hpo ids='HP_0001250'>seizure</z:hpo> control is unattainable, supervision or monitoring may prevent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e>, though this has never been formally tested </plain></SENT>
</text></document>